Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF) Short Interest Up 5.3% in February

Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUFGet Free Report) was the target of a significant growth in short interest in February. As of February 29th, there was short interest totalling 10,140,000 shares, a growth of 5.3% from the February 14th total of 9,626,700 shares. Based on an average daily volume of 4,400 shares, the short-interest ratio is presently 2,304.5 days.

Sumitomo Pharma Stock Performance

Shares of DNPUF stock opened at $2.40 on Wednesday. Sumitomo Pharma has a 52-week low of $2.27 and a 52-week high of $6.33. The stock’s 50-day moving average price is $2.68 and its 200 day moving average price is $3.09.

Sumitomo Pharma Company Profile

(Get Free Report)

Sumitomo Pharma Co, Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia.

Further Reading

Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.